Logo image of NUS

NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:NUS - US67018T1051 - Common Stock

11.54 USD
+0.2 (+1.76%)
Last: 1/16/2026, 8:04:00 PM
11.54 USD
0 (0%)
After Hours: 1/16/2026, 8:04:00 PM
Fundamental Rating

5

NUS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. While NUS has a great health rating, its profitability is only average at the moment. NUS is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year NUS was profitable.
  • In the past year NUS had a positive cash flow from operations.
  • NUS had positive earnings in 4 of the past 5 years.
  • NUS had a positive operating cash flow in each of the past 5 years.
NUS Yearly Net Income VS EBIT VS OCF VS FCFNUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

  • NUS's Return On Assets of 7.69% is fine compared to the rest of the industry. NUS outperforms 75.00% of its industry peers.
  • NUS's Return On Equity of 13.70% is amongst the best of the industry. NUS outperforms 80.56% of its industry peers.
  • The Return On Invested Capital of NUS (4.08%) is comparable to the rest of the industry.
  • NUS had an Average Return On Invested Capital over the past 3 years of 5.22%. This is significantly below the industry average of 11.85%.
Industry RankSector Rank
ROA 7.69%
ROE 13.7%
ROIC 4.08%
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
NUS Yearly ROA, ROE, ROICNUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

  • NUS's Profit Margin of 7.02% is fine compared to the rest of the industry. NUS outperforms 75.00% of its industry peers.
  • NUS's Operating Margin of 3.87% is in line compared to the rest of the industry. NUS outperforms 50.00% of its industry peers.
  • In the last couple of years the Operating Margin of NUS has declined.
  • NUS has a Gross Margin (67.20%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of NUS has declined.
Industry RankSector Rank
OM 3.87%
PM (TTM) 7.02%
GM 67.2%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
NUS Yearly Profit, Operating, Gross MarginsNUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUS is destroying value.
  • NUS has more shares outstanding than it did 1 year ago.
  • NUS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, NUS has an improved debt to assets ratio.
NUS Yearly Shares OutstandingNUS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
NUS Yearly Total Debt VS Total AssetsNUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.84 indicates that NUS is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.84, NUS is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • The Debt to FCF ratio of NUS is 4.29, which is a neutral value as it means it would take NUS, 4.29 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of NUS (4.29) is better than 83.33% of its industry peers.
  • NUS has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.26, NUS is doing good in the industry, outperforming 61.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 4.29
Altman-Z 3.84
ROIC/WACC0.49
WACC8.3%
NUS Yearly LT Debt VS Equity VS FCFNUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 2.15 indicates that NUS has no problem at all paying its short term obligations.
  • NUS's Current ratio of 2.15 is in line compared to the rest of the industry. NUS outperforms 50.00% of its industry peers.
  • A Quick Ratio of 1.45 indicates that NUS should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.45, NUS perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.45
NUS Yearly Current Assets VS Current LiabilitesNUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

  • NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.29%, which is quite impressive.
  • Measured over the past years, NUS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.85% on average per year.
  • Looking at the last year, NUS shows a very negative growth in Revenue. The Revenue has decreased by -12.10% in the last year.
  • Measured over the past years, NUS shows a decrease in Revenue. The Revenue has been decreasing by -6.47% on average per year.
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%

3.2 Future

  • Based on estimates for the next years, NUS will show a very strong growth in Earnings Per Share. The EPS will grow by 29.90% on average per year.
  • Based on estimates for the next years, NUS will show a decrease in Revenue. The Revenue will decrease by -5.77% on average per year.
EPS Next Y54.47%
EPS Next 2Y29.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.05%
Revenue Next 2Y-5.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NUS Yearly Revenue VS EstimatesNUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
NUS Yearly EPS VS EstimatesNUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.36, the valuation of NUS can be described as very reasonable.
  • Based on the Price/Earnings ratio, NUS is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.38. NUS is valued rather cheaply when compared to this.
  • NUS is valuated reasonably with a Price/Forward Earnings ratio of 8.05.
  • NUS's Price/Forward Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 86.11% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.29. NUS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.36
Fwd PE 8.05
NUS Price Earnings VS Forward Price EarningsNUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • NUS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NUS is cheaper than 91.67% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 88.89% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.54
EV/EBITDA 4.62
NUS Per share dataNUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NUS's earnings are expected to grow with 29.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y29.9%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

  • NUS has a Yearly Dividend Yield of 2.12%.
  • NUS's Dividend Yield is a higher than the industry average which is at 1.92.
  • NUS's Dividend Yield is comparable with the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

  • The dividend of NUS decreases each year by -30.50%.
  • NUS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
NUS Yearly Dividends per shareNUS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 10.87% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP10.87%
EPS Next 2Y29.9%
EPS Next 3YN/A
NUS Yearly Income VS Free CF VS DividendNUS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
NUS Dividend Payout.NUS Dividend Payout, showing the Payout Ratio.NUS Dividend Payout.PayoutRetained Earnings

NU SKIN ENTERPRISES INC - A

NYSE:NUS (1/16/2026, 8:04:00 PM)

After market: 11.54 0 (0%)

11.54

+0.2 (+1.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-06
Earnings (Next)02-12
Inst Owners77.1%
Inst Owner Change0.05%
Ins Owners2.11%
Ins Owner Change-1.5%
Market Cap562.58M
Revenue(TTM)1.56B
Net Income(TTM)109.61M
Analysts45
Price TargetN/A
Short Float %4.83%
Short Ratio5.08
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP10.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.99%
Min EPS beat(2)12.21%
Max EPS beat(2)73.77%
EPS beat(4)4
Avg EPS beat(4)59.11%
Min EPS beat(4)12.21%
Max EPS beat(4)76.64%
EPS beat(8)7
Avg EPS beat(8)43.78%
EPS beat(12)10
Avg EPS beat(12)34.6%
EPS beat(16)13
Avg EPS beat(16)24.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)1.5%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)-1.28%
Revenue beat(16)7
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.09%
EPS NY rev (1m)0%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.24%
Valuation
Industry RankSector Rank
PE 8.36
Fwd PE 8.05
P/S 0.36
P/FCF 10.54
P/OCF 6.29
P/B 0.7
P/tB 0.84
EV/EBITDA 4.62
EPS(TTM)1.38
EY11.96%
EPS(NY)1.43
Fwd EY12.43%
FCF(TTM)1.09
FCFY9.48%
OCF(TTM)1.83
OCFY15.9%
SpS32.01
BVpS16.41
TBVpS13.78
PEG (NY)0.15
PEG (5Y)N/A
Graham Number22.57
Profitability
Industry RankSector Rank
ROA 7.69%
ROE 13.7%
ROCE 5.16%
ROIC 4.08%
ROICexc 5.21%
ROICexgc 6.05%
OM 3.87%
PM (TTM) 7.02%
GM 67.2%
FCFM 3.42%
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 4.29
Debt/EBITDA 1.8
Cap/Depr 64.7%
Cap/Sales 2.31%
Interest Coverage 250
Cash Conversion 76.96%
Profit Quality 48.67%
Current Ratio 2.15
Quick Ratio 1.45
Altman-Z 3.84
F-Score6
WACC8.3%
ROIC/WACC0.49
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
EPS Next Y54.47%
EPS Next 2Y29.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
Revenue Next Year-13.05%
Revenue Next 2Y-5.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.66%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y-0.72%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%

NU SKIN ENTERPRISES INC - A / NUS FAQ

Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?

ChartMill assigns a fundamental rating of 5 / 10 to NUS.


What is the valuation status of NU SKIN ENTERPRISES INC - A (NUS) stock?

ChartMill assigns a valuation rating of 8 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.


How profitable is NU SKIN ENTERPRISES INC - A (NUS) stock?

NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for NUS stock?

The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 8.36 and the Price/Book (PB) ratio is 0.7.


Can you provide the dividend sustainability for NUS stock?

The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 4 / 10 and the dividend payout ratio is 10.87%.